Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-3 of 3 for your search:
Drug:
autologous dendritic cell-adenovirus p53 vaccine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Randomized Study of Standard First-Line Chemotherapy Comprising Carboplatin and Etoposide Followed by Observation Versus Autologous Dendritic Cell-Adenovirus p53 Vaccine With Versus Without Tretinoin in Patients With Extensive Stage Small Cell Lung Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
MCC-15206
, MCC-IRB-9792, MCC 15206, INTROGEN-RAC-0705-857, NCT00618891
2.
Autologous PBHCT Followed by Dendritic Cell p53 Vaccination & Adoptive T Cell Transfer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MCC-14955
, USFIRB#105632, NCT00609583
3.
Phase II Study of Anti-p53 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes, High-Dose Aldesleukin, and Adenovirus p53 Dendritic Cell Vaccine in Patients With Progressive or Recurrent Metastatic Cancer That Overexpresses p53
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-08-C-0155
, 08-C-0155, NCI-P07215, NCT00704938
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute